Quality of Life Research Award
Forecasted
METAvivor’s Quality of Life Research Award funds clinical and translational studies developing interventions to improve quality of life for metastatic breast cancer patients, with required patient advocate involvement.
Browse similar grants
Funder: METAvivor
Due Dates (Anticipated): August 2026 (Internal submission, projected) | December 2026 (Full application, projected)
Funding Amounts: Up to $200,000 total over 2 years; only one application per applicant
Summary: Supports translational and clinical research to improve quality of life or mitigate side effects for individuals with metastatic breast cancer, requiring meaningful patient advocate involvement.
Key Information: Applications must propose mechanism-based interventions and include patient advocate participation in both application and project phases.
Description
This award funds translational and clinical research projects aimed at improving the quality of life or reducing side effects for people living with metastatic (stage IV) breast cancer. Projects must be grounded in strong scientific rationale, focused on mechanism-based interventions, and demonstrate clear potential to help patients live longer and better lives. Active, meaningful involvement of experienced patient advocates is required throughout both the planning and execution phases of the research. Proposals that simply document quality of life issues or side effects, without a substantive intervention plan, are not eligible.
Preference is given to projects with direct potential to enhance day-to-day experiences for metastatic breast cancer patients. Applications must detail advocate involvement and provide biosketches demonstrating team qualifications.
